This overview is designed to provide a summary of the major legal and ethical issues related to the development and delivery of an HIV vaccine in Canada. The main target audience is people working in community-based HIV/AIDS organizations. Secondary target audiences are researchers working on HIV vaccines and government officials working in HIV/AIDS. The overview … Read more
This info sheet summarizes the main findings of a November 2002 report by the Legal Network, entitled “Action on HIV/AIDS in Prisons: Too Little, Too Late — A Report Card”
This info sheet summarizes the main findings of a November 2002 report by the Legal Network, entitled “Action on HIV/AIDS in Prisons: Too Little, Too Late — A Report Card” (see Related Publications, below).
Background information for: support of the HIV vaccine effort in a human rights framework advocacy for national plans and funding commitments advocacy for public awareness, support, and involvement advocacy for HIV vaccine development advocacy for future HIV vaccine access
This background paper notes the imperatives for funding HIV vaccine research for developing countries; the inadequacy of current approaches and the obstacles to more rapid research and development; and potential action steps to quickly mobilize substantially greater support for such research, including greater funding from governments and other donors and the private sector, and greater … Read more
This is a series of eight info sheets: Current State of HIV Vaccine Research Why We Need a Canadian HIV Vaccine Plan Involving Communities in the Conduct of Clinical Trials Clinical Trials and the Informed-Consent Process Obligations Toward Clinical Trial Participants Clinical Trials and Stigma & Discrimination Planning Now for Vaccine Delivery Essential Resources
At least three international developments are worth noting: the outcomes of the UN General Assembly Special Session on HIV/AIDS in June 2001; the establishment of a Global Fund to fight AIDS, Tuberculosis and Malaria; and the Declaration on the TRIPS Agreement and Public Health adopted at the recent 4th WTO Ministerial Conference (Doha, November 2001).
The paper demonstrates that promoting the well-being of both drug users and communities requires changes to drug laws and policies, including the introduction of safe injection facilities.